RAMM Pharma (XCNQ:RAMM) Cash-to-Debt : 4.33 (As of Oct. 2024)

View and export this data going back to 2019. Start your Free Trial

What is RAMM Pharma Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. RAMM Pharma's cash to debt ratio for the quarter that ended in Oct. 2024 was 4.33.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, RAMM Pharma could pay off its debt using the cash in hand for the quarter that ended in Oct. 2024.

The historical rank and industry rank for RAMM Pharma's Cash-to-Debt or its related term are showing as below:

XCNQ:RAMM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.18 Med: 14.29 Max: 536.09
Current: 4.33

During the past 7 years, RAMM Pharma's highest Cash to Debt Ratio was 536.09. The lowest was 0.18. And the median was 14.29.

XCNQ:RAMM's Cash-to-Debt is ranked better than
68.12% of 1010 companies
in the Drug Manufacturers industry
Industry Median: 1.02 vs XCNQ:RAMM: 4.33

RAMM Pharma Cash-to-Debt Historical Data

The historical data trend for RAMM Pharma's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

RAMM Pharma Cash-to-Debt Chart

RAMM Pharma Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Cash-to-Debt

Get a 7-Day Free Trial

280.06

536.09

14.29

12.64

4.33

RAMM Pharma Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Cash-to-Debt	Get a 7-Day Free Trial															12.64	11.06	9.19	6.08	4.33

Competitive Comparison of RAMM Pharma's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, RAMM Pharma's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RAMM Pharma's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RAMM Pharma's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where RAMM Pharma's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

RAMM Pharma Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

RAMM Pharma's Cash to Debt Ratio for the fiscal year that ended in Oct. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.814	/	(0.103	+	0.085)
	=	4.33

RAMM Pharma's Cash to Debt Ratio for the quarter that ended in Oct. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.814	/	(0.103	+	0.085)
	=	4.33

RAMM Pharma (XCNQ:RAMM) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

RAMM Pharma Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of RAMM Pharma's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

RAMM Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RAMM Pharma Corp (XCNQ:RAMM) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street E, Toronto, ON, CAN, M5C 1P1

Website

https://www.rammpharma.com

RAMM Pharma Corp is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue primarily from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of revenue from Uruguay.

Executives

Jackie Peter Burnett	10% Security Holder, Director, Senior Officer
Armando Gabriel Blankleider	Director

RAMM Pharma Headlines

No Headlines